Cagrilintide research peptide
A stable, lipidated, long-acting analogue of the pancreatic hormone amylin that agonises amylin and calcitonin receptors.
Sizes, prices and availability
| Size | SKU | Stated purity | Batch COA | Price | Availability | |
|---|---|---|---|---|---|---|
| 5 mg | CGL5 | Not yet provided | Not yet provided | $32.99 | In stock | |
| 10 mg | CGL10 | Not yet provided | Not yet provided | $40.99 | In stock |
Blend vials containing Cagrilintide
| Size | SKU | Stated purity | Batch COA | Price | Availability | |
|---|---|---|---|---|---|---|
| Cagrilintide 2.5mg + Semaglutide 2.5mg | CS5 | Not yet provided | Not yet provided | $24.99 | Out of stock | |
| Cagrilintide 5mg + Semaglutide 5mg | CS10 | Not yet provided | Not yet provided | $44.99 | Out of stock | |
| Retatrutide 5mg + Cagrilintide 5mg | RC10 | Not yet provided | Not yet provided | $25.99 | Out of stock |
Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details
About Cagrilintide
Cagrilintide is a long-acting analogue of amylin, a pancreatic hormone that is hard to work with because it readily forms amyloid fibrils. The Journal of Medicinal Chemistry paper that describes it reports a stable, lipidated analogue selected from structure-activity work, in the context of the commercially available amylin analogue pramlintide, which has a short half-life.
Mechanistic work describes cagrilintide as a dual amylin and calcitonin receptor agonist. A 2025 study in RAMP1 and RAMP3 knockout mice examined the roles of the AMY1 and AMY3 receptors in its effects.
What the published literature covers
- Kruse et al. (2021) report the development of cagrilintide and the structure-activity work behind its selection.
- Carvas et al. (2025) examine the role of amylin receptors 1 and 3 in the effects of cagrilintide in knockout mice.
- Lau et al. (2021, The Lancet) report a phase 2 dose-finding trial; combination studies with semaglutide are also published.
Vial arithmetic
The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter, and the peptide blend calculator covers the blend vials. It does arithmetic only and does not suggest any amount.
FAQ
What kind of molecule is cagrilintide?
It is a long-acting, lipidated analogue of the hormone amylin (Kruse et al., 2021) and is described as a dual amylin and calcitonin receptor agonist (Carvas et al., 2025).
How does cagrilintide differ from semaglutide?
Cagrilintide is an amylin analogue acting at amylin and calcitonin receptors. Semaglutide is a GLP-1 analogue acting at the GLP-1 receptor. Studies of the two together are in the literature.
What sizes of Cagrilintide does Covalume list?
Covalume lists Cagrilintide in 2 sizes: 5 mg, 10 mg. Each size shows its price and live stock status in the variants table on this page.
How is the purity of Cagrilintide documented?
Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.
References
- Kruse T, Hansen JL, Dahl K, et al. (2021). Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem 64:11183-11194. PubMed 34288673 · DOI
- Carvas AO, Leuthardt A, Kulka P, et al. (2025). Cagrilintide lowers bodyweight through brain amylin receptors 1 and 3. EBioMedicine 118:105836. PubMed 40609154 · DOI
- Lau DCW, Erichsen L, Francisco AM, et al. (2021). Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet 398:2160-2172. PubMed 34798060 · DOI
Identity values are from PubChem (CID 171397054) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-18.
Related research peptides
- Semaglutide GLP-1 receptor agonist peptide analogue
- Tirzepatide Dual GIP and GLP-1 receptor agonist peptide
- Retatrutide Triple GIP, GLP-1 and glucagon receptor agonist peptide
- Survodutide Dual glucagon and GLP-1 receptor agonist peptide
- All glp-1 research peptides
From the research library
- Peptide purity: HPLC and mass spectrometry explained
- Peptide reconstitution: concentration and volume math
- CagriSema: cagrilintide plus semaglutide
- Peptide purity vs peptide content: a vial mass balance
- Check the mass spectrometry on a COA yourself
- How to read a COA HPLC chromatogram
- HPLC vs LC-MS for peptides: identity and purity workflow
- How to read an LC-MS trace: a worked peptide example
- TFA to acetate: peptide counter-ion exchange
- Peptide net charge, pI and solubility by pH
- Peptide adsorption to vials and plastics
- How long do peptides last? Stability evidence explained
- Bacteriostatic water vs sterile water